Showing 3 Abstracts.
Mezher Maria, Hamel Eva, States Lisa
Final Pr. ID: Poster #: SCI-070
68-Gallium DOTATATE PET is frequently utilized for the assessment of neuroendocrine tumors. Its application in the management of neuroblastoma has been briefly documented in the literature. We describe four years of institutional experience of its use for the evaluation and follow-up of neuroblastoma. Read More
Authors: Mezher Maria , Hamel Eva , States Lisa
Keywords: Neuroblastoma, Ganglioneuroblastoma, Paediatric Nuclear Medicine
Final Pr. ID: Poster #: CR-004 (T)
A three year old child was referred to the Nuclear Medicine Department for bone scintigraphy for staging. This patient was diagnosed with hepatoblastoma. Imaging findings showed no bony disease, however, radiotracer uptake was demonstrated throughout the liver. Read More
Authors: Mannix Laura
Keywords: Nuclear Medicine, Heptoblastoma, Paediatric Nuclear Medicine
Antil Neha, Gatidis Sergios, Nadel Helen
Final Pr. ID: Poster #: EDU-110
PET/MRI (Positron Emission Tomography–Magnetic Resonance Imaging) is a powerful hybrid imaging modality that has gained increasing clinical relevance in pediatric and neonatal imaging over the past decade. It combines the molecular imaging strengths of PET with the superior soft tissue contrast and functional capabilities of MRI, enabling both whole-body and targeted imaging in a single session. In pediatric imaging, where minimizing radiation exposure is critical and conditions often involve subtle functional or metabolic changes, PET/MRI has emerged as a powerful problem-solving modality. Additional advantage of PET/MRI in pediatric patients is reduction in the number of necessary single examinations and thus reducing the number of sedations and radiation exposure when compared with PET/CT.
PET/MRI has been established as a clinical imaging modality with a wide range of applications across pediatric oncology, neurology, cardiology, infectious/ inflammatory disorders, and rheumatology. It can be utilized for presurgical planning for epilepsy, detection and staging of tumors. Beyond detection and characterization of tumor lesions, PET/MRI is highly effective in providing relevant secondary information about tumor-related or therapy-related complications. Additionally, PET/MRI is helpful diagnostic tool in unusual or challenging clinical situations such as discrepant findings from other diagnostic tests, nonspecific clinical findings, or inconclusive prior imaging findings, especially in children with fever of unknown origin. In such settings, PET/MRI can be used as a problem-solving tool to provide guidance regarding patient management when identifying disease foci or biopsy targets or when ruling out the presence of macroscopic malignancy or active inflammatory processes.
This exhibit demonstrates the unique diagnostic value of hybrid PET/MRI in complex pediatric imaging and to highlight its role as a comprehensive, multiparametric tool in evaluating a wide spectrum of challenging pediatric conditions through clinical cases. The exhibit will be educational for radiologists, nuclear medicine physicians, and pediatric specialists on the strengths, clinical applications, and practical considerations of PET/MRI in children.
Read More
Authors: Antil Neha , Gatidis Sergios , Nadel Helen